Shareholders will be ecstatic, with their stake up 20% over the past week following Bionano Genomics, Inc.'s (NASDAQ:BNGO) latest full-year results. The results don't look great, especially ...

Full Year 2024 Results Key Financial Results Revenue: US$30.8m (down 15% from ...

Scotiabank raised the firm’s price target on Bionano Genomics (BNGO) to $4 from $1 and keeps a Sector Perform rating on the shares. Despite the ...

Operator Good day, and welcome to the Bionano fourth quarter 2024 earnings conference call. Today's conference is being ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook ...

Discover Bionano Genomics' Q4 2024 earnings insights, focusing on operational efficiency, core customer utilization, and 2025 growth strategies with new ...

Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40. The announcement from Bionano ...

Bionano Genomics Inc (BNGO) reports improved gross margins and reduced operating expenses, while facing revenue declines and ...

Q4 2024 Earnings Call Transcript March 31, 2025 Bionano Genomics, Inc. reports earnings inline with expectations. Reported ...

Good day, and welcome to the Bionano Fourth Quarter 2024 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bionano Genomics wasn’t one of them. The 10 stocks that made ...

Good day, and welcome to the Bionano fourth quarter 2024 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...